Abstract
Osteosarcoma,
a
leading
primary
bone
malignancy
in
children
and
adolescents,
is
associated
with
poor
prognosis
low
global
fertility
rate.
A
large
language
model‐assisted
phenolic
network
(LLMPN)
platform
demonstrated
that
integrates
the
model
(LLM)
GPT‐4
into
design
of
multifunctional
metal‐phenolic
materials.
Fine‐tuned
identified
gossypol
as
compound
superior
efficacy
against
osteosarcoma
after
evaluating
across
library
60
polyphenols
based
on
correlation
between
experimental
anti‐osteosarcoma
activity
multiplexed
chemical
properties
polyphenols.
Subsequently,
then
self‐assembled
Cu
2+
‐gossypol
nanocomplexes
hyaluronic
acid
surface
modification
(CuGOS
NPs).
CuGOS
NPs
has
ability
to
induce
genetic
alterations
cell
death
cells,
offering
significant
therapeutic
benefits
for
tumors
reducing
metastasis
without
adverse
effects
major
organs
or
genital
system.
This
work
presents
an
LLM‐driven
approach
engineering
metal‐organic
nanoplatform
broadening
applications
by
harnessing
capabilities
LLMs,
thereby
improving
feasibility
efficiency
research
activities.
Advanced Materials,
Год журнала:
2024,
Номер
36(45)
Опубликована: Сен. 17, 2024
Abstract
The
overexpression
of
polyamines
in
tumor
cells
contributes
to
the
establishment
immunosuppressive
microenvironment
and
facilitates
growth.
Here,
it
have
ingeniously
designed
multifunctional
copper‐piceatannol/HA
nanopills
(Cu‐Pic/HA
NPs)
that
effectively
cause
total
intracellular
depletion
by
inhibiting
synthesis,
depleting
polyamines,
impairing
uptake,
resulting
enhanced
pyroptosis
cuproptosis,
thus
activating
a
powerful
immune
response
achieve
anti‐tumor
therapy.
Mitochondrial
dysfunction
from
overall
not
only
leads
surge
copper
ions
mitochondria,
thereby
causing
aggregation
toxic
proteins
induce
but
also
triggers
accumulation
reactive
oxygen
species
(ROS)
within
which
further
upregulates
expression
zDHHC5
zDHHC9
promote
palmitoylation
gasdermin
D
(GSDMD)
GSDMD‐N,
ultimately
inducing
pyroptosis.
Then
occurrence
cuproptosis
is
conductive
remodel
microenvironment,
responses
growth
metastasis.
This
therapeutic
strategy
through
comprehensive
provides
novel
template
for
cancer
immunotherapy.
Abstract
Immunotherapy
is
a
promising
new
approach
for
tumor
treatment.
However,
its
clinical
application
hindered
by
insufficient
immunogenicity,
hypoxia,
and
immunosuppressive
microenvironment
(TME).
Here,
oxygen
pump
microneedles
(OPMNs)
loaded
with
zinc‐doped
copper
sulfide
nanoflowers
(ZCS
NFs)
PD‐L1
small
interfering
RNA
(siPD‐L1)
(OPMNs‐ZCS@siPD‐L1)
are
developed
boosting
immunotherapy.
OPMN‐ZCS@siPD‐L1
enhances
immunogenicity
through
ZCS
NFs
inducing
cuproptosis,
reverses
TME
siPD‐L1,
promotes
drug
penetration,
ameliorates
hypoxia
bubbles.
More
importantly,
cuproptosis‐induced
mitochondrial
DNA
(mtDNA)
together
Zn
2+
co‐activate
the
STING
pathway,
triggering
robust
immune
response.
increases
sensitivity
to
cuproptosis
induces
immunogenic
cell
death
(ICD)
in
vivo
vitro,
which
significantly
inhibits
progression
metastasis.
The
novel
strategy
of
“increasing
throttle”
(cuproptopsis‐mediated
activation
&
ICD
effect)
combined
“releasing
brake”
(PD‐L1
inhibition
improvement)
provides
enhancing
percutaneous
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
13(22)
Опубликована: Май 1, 2024
Abstract
The
immunosuppressive
tumor
microenvironment
(ITME)
of
osteosarcoma
(OS)
poses
a
significant
obstacle
to
the
efficacy
existing
immunotherapies.
Despite
attempt
novel
immune
strategies
such
as
checkpoint
inhibitors
and
vaccines,
their
effectiveness
remains
suboptimal
due
inherent
difficulty
in
mitigating
ITME
simultaneously
from
both
system.
promotion
anti‐tumor
immunity
through
induction
immunogenic
cell
death
activation
cGAS‐STING
pathway
has
emerged
potential
counter
stimulate
systemic
antitumor
responses.
Here,
bimetallic
polyphenol‐based
nanoplatform
(Mn/Fe‐Gallate
nanoparticles
coated
with
membranes
is
presented,
MFG@TCM)
which
combines
mild
photothermal
therapy
(PTT)
for
reversing
via
inducing
pyroptosis
OS
cells
activating
dendritic
(DCs).
immunostimulatory
pathways,
syngeneic
effect,
exerted
substantial
positive
impact
on
promoting
secretion
damage‐associated
molecular
patterns
(DAMPs)
proinflammatory
cytokines,
favors
remodeling
microenvironment.
Consequently,
effector
T
led
notable
response,
effectively
inhibiting
growth
primary
distant
tumors.
This
study
proposes
new
method
treating
using
PTT
mudulation,
showing
promise
overcoming
current
treatment
limitations.
Lipid
nanoparticles
(LNPs)
are
the
most
clinically
successful
drug
delivery
systems
that
have
accelerated
development
of
mRNA
drugs
and
vaccines.
Among
various
structural
components
LNPs,
more
recent
attention
has
been
paid
in
ionizable
lipids
(ILs)
was
supposed
as
key
component
determining
effectiveness
LNPs
for
vivo
delivery.
ILs
typically
comprised
three
moieties
including
heads,
linkers,
hydrophobic
tails,
which
suggested
combination
different
functional
groups
could
produce
with
diverse
chemical
structures
biological
identities.
In
this
concept
article,
we
provide
a
summary
design
strategy
high-performing
IL
candidates
discuss
their
structure-activity
relationships
shifting
tissue-selective
We
also
propose
an
outlook
next-generation
ILs,
enabling
broader
translation
formulated
LNPs.
Pharmaceutics,
Год журнала:
2024,
Номер
16(8), С. 972 - 972
Опубликована: Июль 23, 2024
Cancer
remains
a
highly
lethal
disease
globally.
The
approach
centered
on
REDOX-targeted
mitochondrial
therapy
for
cancer
has
displayed
notable
benefits.
Plant
polyphenols
exhibit
strong
REDOX
and
anticancer
properties,
particularly
by
affecting
function,
yet
their
structural
instability
low
bioavailability
hinder
utility.
To
overcome
this
challenge,
researchers
have
utilized
the
inherent
physical
chemical
characteristics
of
derivatives
to
develop
innovative
nanomedicines
targeting
mitochondria.
This
review
examines
construction
strategies
properties
various
types
polyphenol-based
biological
nanomedicine
regulating
mitochondria
in
recent
years,
such
as
polyphenol
self-assembly,
metal–phenol
network,
polyphenol–protein,
polyphenol–hydrogel,
polyphenol–chitosan,
polyphenol–liposome.
These
polyphenolic
incorporate
enhanced
features
improved
solubility,
efficient
photothermal
conversion
capability,
regulation
homeostasis,
ion
adsorption
through
diverse
strategies.
focus
is
how
these
promote
ROS
production
mechanism
inhibit
cancer.
Furthermore,
it
delves
into
benefits
applications
treatments,
well
challenges
future
research.
Bioactive Materials,
Год журнала:
2024,
Номер
37, С. 439 - 458
Опубликована: Апрель 25, 2024
Facile
and
rapid
3D
fabrication
of
strong,
bioactive
materials
can
address
challenges
that
impede
repair
large-to-massive
rotator
cuff
tears
including
personalized
grafts,
limited
mechanical
support,
inadequate
tissue
regeneration.
Herein,
we
developed
a
facile
methodology
generates
visible
light-crosslinkable
polythiourethane
(PHT)
pre-polymer
resin
(∼30
min
at
room
temperature),
yielding
3D-printable
scaffolds
with
tendon-like
attributes
capable
delivering
tenogenic
factors.
Ex
vivo
characterization
confirmed
successful
fabrication,
robust
human
supraspinatus
tendon
(SST)-like
tensile
properties
(strength:
23
MPa,
modulus:
459
least
10,000
physiological
loading
cycles
without
failure),
excellent
suture
retention
(8.62-fold
lower
than
acellular
dermal
matrix
(ADM)-based
clinical
graft),
slow
degradation,
controlled
release
fibroblast
growth
factor-2
(FGF-2)
transforming
factor-β3
(TGF-β3).
In
vitro
studies
showed
cytocompatibility
factor-mediated
tenogenic-like
differentiation
mesenchymal
stem
cells.
demonstrated
biocompatibility
(3-week
mouse
subcutaneous
implantation)
ability
factor-containing
to
notably
regenerate
1-cm
native-like
biomechanical
as
uninjured
shoulder
(8-week,
gap
rabbit
injury).
This
study
demonstrates
use
3D-printable,
material
provide
support
pro-regenerative
cues
for
challenging
injuries
such
tears.
Chemical Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Polyphenol-functionalized
nanoarchitectures
(cytoPNAs)
provide
a
modular
and
cell
independent
strategy
to
create
biohybrids
for
engineering,
with
improved
production
biomanufacturing
enhanced
efficacy
cell-based
therapies.